Halozyme Therapeutics (LTS:0J2O) Days Payable : 25.69 (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Halozyme Therapeutics Days Payable?

Halozyme Therapeutics's average Accounts Payable for the three months ended in Sep. 2024 was $13.9 Mil. Halozyme Therapeutics's Cost of Goods Sold for the three months ended in Sep. 2024 was $49.4 Mil. Hence, Halozyme Therapeutics's Days Payable for the three months ended in Sep. 2024 was 25.69.

The historical rank and industry rank for Halozyme Therapeutics's Days Payable or its related term are showing as below:

LTS:0J2O' s Days Payable Range Over the Past 10 Years
Min: 7.78 Med: 43.26 Max: 216.55
Current: 31.1

During the past 13 years, Halozyme Therapeutics's highest Days Payable was 216.55. The lowest was 7.78. And the median was 43.26.

LTS:0J2O's Days Payable is ranked worse than
82.21% of 714 companies
in the Biotechnology industry
Industry Median: 127.14 vs LTS:0J2O: 31.10

Halozyme Therapeutics's Days Payable increased from Sep. 2023 (24.50) to Sep. 2024 (25.69). It may suggest that Halozyme Therapeutics delayed paying its suppliers.

Halozyme Therapeutics Days Payable Historical Data

The historical data trend for Halozyme Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Halozyme Therapeutics Days Payable Chart

Halozyme Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

42.12

35.19

7.78

25.20

28.00

Halozyme Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Days Payable	Get a 7-Day Free Trial															24.50	27.16	40.49	33.12	25.69

Competitive Comparison of Halozyme Therapeutics's Days Payable

For the Biotechnology subindustry, Halozyme Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Halozyme Therapeutics's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Halozyme Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where Halozyme Therapeutics's Days Payable falls into.

Halozyme Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Halozyme Therapeutics's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (17.693	+	11.816)	/	2 )	/	192.361	*	365
=	14.7545					/	192.361	*	365
=	28.00

Halozyme Therapeutics's Days Payable for the quarter that ended in Sep. 2024 is calculated as:

	Days Payable (Q: Sep. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2024 )	+	Accounts Payable (Q: Sep. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2024 )	*	Days in Period
=	( (15.43	+	12.398)	/	2 )	/	49.426	*	365 / 4
=	13.914					/	49.426	*	365 / 4
=	25.69

Halozyme Therapeutics Days Payable Related Terms

Thank you for viewing the detailed overview of Halozyme Therapeutics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Halozyme Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Halozyme Therapeutics Inc (LTS:0J2O) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

HALO:USA RV7:Germany

Address

12390 El Camino Real, San Diego, CA, USA, 92130

Website

https://www.halozyme.com

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Halozyme Therapeutics Headlines

No Headlines